Bigler-Engler v. Breg, Inc.

California Court of Appeal·Decided October 28, 2016·No. D063556·Published

Opinion

Filed 10/28/16

CERTIFIED FOR PARTIAL PUBLICATION*

COURT OF APPEAL, FOURTH APPELLATE DISTRICT DIVISION ONE

STATE OF CALIFORNIA

VIRGINIA BIGLER-ENGLER, as D063556 Administrator, etc.,

Plaintiff and Appellant,

v.

(Super. Ct. No. GIC870982)

BREG, INC. et al.,

Defendants and Appellants.

APPEALS from a judgment of the Superior Court of San Diego County, Ronald S.

Prager, Judge. Affirmed in part; reversed in part with directions.

Law Office of Marc O. Stern and Marc O. Stern; Boudreau Williams and Jon R.

Williams; Williams Iagmin and Jon R. Williams, for Plaintiff and Appellant Virginia Bigler-Engler, as Administrator, etc.

* Pursuant to California Rules of Court, rule 8.1110, this opinion is certified for publication with the exception of discussion parts I.; IV. C., D., E.; V. A.; VI.; and VIII.

Bowman & Brooke and Michael J. Hurvitz; Gibson, Dunn & Crutcher, Theodore J. Boutrous, Jr., Daniel J. Thomasch, and Blaine H. Evanson, for Defendant and Appellant Breg, Inc.

Cole Pedroza, Kenneth R. Pedroza, Matthew S. Levinson and Joshua C. Traver;

Neil, Dymott, Frank, McFall & Trexler, Clark Hudson and Jonathan R. Ehtessabian, for Defendant and Appellant David J. Chao, M.D.

Law Offices of Adrienne D. Cohen, Adrienne D. Cohen, Danielle M. Dalton and Julie R. Ursic, for Defendant and Appellant Oasis MSO, Inc.

This matter arises from Whitney Engler's use of a medical device, the Polar Care 500, that was manufactured by Breg, Inc. (Breg) and prescribed by David Chao, a medical doctor. Engler suffered injuries as a result of her use of the Polar Care 500, and she brought various tort claims against Chao, his medical group Oasis MSO, Inc. (Oasis), and Breg, among others.

At trial, the jury considered Engler's claims for medical malpractice, design defect (under theories of negligence and strict liability), failure to warn (also under theories of negligence and strict liability), breach of fiduciary duty, intentional misrepresentation, and intentional concealment. With a few exceptions, the jury generally found in favor of Engler, and against the defendants, on these claims. The jury awarded $68,270.38 in economic compensatory damages and $5,127,950 in noneconomic compensatory damages to Engler. It allocated responsibility for Engler's harm as follows: 50 percent to Chao, 10 percent to Oasis, and 40 percent to Breg.

The jury made findings of malice, oppression, or fraud as to each defendant on at least one claim. In the punitive damages phase of trial, the jury awarded $500,000 against Chao and $7 million against Breg. The jury declined to award any punitive damages against Oasis.

Breg, Chao, Oasis, and Virginia Bigler-Engler, as administrator of Engler's estate, appeal.1 They raise numerous challenges to the judgment. In the published portions of this opinion, we consider the following issues: (1) whether Engler's counsel committed prejudicial misconduct during trial; (2) whether the jury's awards of noneconomic compensatory damages and punitive damages are excessive; (3) whether the evidence supported the jury's verdict against Breg for intentional concealment in the absence of a transactional relationship between Breg and Engler (or her parents); (4) whether Oasis falls within the medical provider exception to the doctrine of strict products liability; (5) whether Breg was entitled to an instruction on the learned intermediary doctrine; and (6) whether the Medical Injury Compensation Reform Act of 1975 (MICRA) (Civ. Code, § 3333.2) and Proposition 51 (Civ. Code, § 1431 et seq.) apply to the jury's verdict. In the unpublished portions of the opinion, we consider additional challenges to the sufficiency of the evidence, the trial court's jury instructions, the trial court's evidentiary rulings and a posttrial order taxing costs.

1 Tragically, Engler was killed during the pendency of this appeal. Following her death, Bigler-Engler was appointed administrator of Engler's estate. In that capacity, Bigler-Engler has been substituted in place of Engler in this appeal.

For reasons we will explain, we reverse the judgment in part. We conclude the jury's verdict as to several claims was not supported by the evidence, including Engler's intentional concealment claim against Breg and her strict products liability claim against Oasis. In light of our reversal of Engler's intentional concealment claim against Breg, the jury's punitive damages award against Breg must be reversed as well.

We further conclude the jury's award of noneconomic compensatory damages and the jury's award of punitive damages as to Chao are excessive. Those awards will be reversed as well and remanded for a new trial unless Bigler-Engler accepts reductions in those awards to $1,300,000 and $150,000 respectively. In all other respects, the judgment is affirmed.

FACTUAL AND PROCEDURAL BACKGROUND "As required by the rules of appellate procedure, we state the facts in the light most favorable to the judgment." (Orthopedic Systems, Inc. v. Schlein (2011) 202 Cal.App.4th 529, 532, fn. 1.) In this section we provide an overview of those facts necessary to understand the disputed issues in these appeals. Additional relevant facts will be discussed in the following sections.2 In 2003, Engler, a high school athlete, consulted Chao regarding possible surgery on her left knee. Engler had injured her knee while running hurdles and suffered from

2 We note that Bigler-Engler's statement of facts in her respondent's brief is inadequate. Significant portions discuss documents and statements that were not admitted at trial (such as premarked or identified exhibits) as if they provided a basis for the jury's verdict. Throughout her briefing, Bigler-Engler does not distinguish between facts derived from evidence actually admitted at trial and other facts.

pain and weakness, especially during sports. Chao identified the presence of a loose body underneath her patella and diagnosed Engler with "patella alta" (misalignment of the patella). Chao also noted a possible tear in Engler's meniscus. Chao recommended arthroscopic surgery. He provided Engler and her parents with a written disclosure of the risks of surgery, which Engler's mother signed.

Chao recommended that Engler use a Polar Care 500 device after surgery. The Polar Care device, manufactured by Breg, is a Class II medical device under California law, available only by prescription. The Polar Care device is intended to deliver cold therapy to the site of surgery or injury, along the same general lines as an icepack or bag of frozen vegetables. The Polar Care device consists of a reservoir of ice water, a small pump, and a pad to be placed on the site of surgery or injury. The pump circulates cold water through the pad. A dial controls the amount of water that can flow through the pad. This dial is intended to affect the temperature of the pad, i.e., as the amount of water flowing through the pad decreases, the water flows more slowly through the pad and the patient's body has a greater opportunity to warm it. A thermometer displays the temperature of the water exiting the pad. The Polar Care device can operate continuously for up to 11 hours before the reservoir of ice must be refilled.

Chao told Engler and her parents that the Polar Care device was superior to traditional methods of cold therapy, such as an icepack, because it could be used "continuously" rather than intermittently. Chao said the Polar Care device would decrease her risk of infection and otherwise help Engler recover from her surgery. Chao

did not disclose any risks of using the Polar Care device, even though he knew risks existed.

Free access — add to your briefcase to read the full text and ask questions with AI

Bigler-Engler v. Breg, Inc., (Cal. Ct. App. 2016).

Bigler-Engler v. Breg, Inc. (Bigler-Engler v. Breg, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

State Farm Mutual Automobile Insurance v. Campbell
538 U.S. 408 (Supreme Court, 2003)
Rayii v. Gatica CA2/3
218 Cal. App. 4th 1402 (California Court of Appeal, 2013)
Boeken v. Philip Morris USA Inc.
217 Cal. App. 4th 992 (California Court of Appeal, 2013)
Rouland v. Pacific Specialty Insurance
220 Cal. App. 4th 280 (California Court of Appeal, 2013)
Ford Motor Company v. Buell-Wilson
127 S. Ct. 2250 (Supreme Court, 2007)
Stevens v. Parke, Davis & Co.
507 P.2d 653 (California Supreme Court, 1973)
Seffert v. Los Angeles Transit Lines
364 P.2d 337 (California Supreme Court, 1961)
Norgart v. Upjohn Co.
981 P.2d 79 (California Supreme Court, 1999)
Isaacs v. Huntington Memorial Hospital
695 P.2d 653 (California Supreme Court, 1985)
DaFonte v. Up-Right, Inc.
828 P.2d 140 (California Supreme Court, 1992)
Warner Construction Corp. v. City of Los Angeles
466 P.2d 996 (California Supreme Court, 1970)
Brewer v. Second Baptist Church
197 P.2d 713 (California Supreme Court, 1948)
Central Pathology Service Medical Clinic, Inc. v. Superior Court
832 P.2d 924 (California Supreme Court, 1992)
Goodman v. Kennedy
556 P.2d 737 (California Supreme Court, 1976)
Palmer v. City of Long Beach
199 P.2d 952 (California Supreme Court, 1948)
Potter v. Firestone Tire & Rubber Co.
863 P.2d 795 (California Supreme Court, 1993)
Strong v. County of Santa Cruz
543 P.2d 264 (California Supreme Court, 1975)
Carlin v. Superior Court
920 P.2d 1347 (California Supreme Court, 1996)
Murphy v. E. R. Squibb & Sons, Inc.
710 P.2d 247 (California Supreme Court, 1985)
People v. Calio
724 P.2d 1162 (California Supreme Court, 1986)